Skip to main content
. 2017 Nov 17;96(46):e8696. doi: 10.1097/MD.0000000000008696

Figure 3.

Figure 3

Effect of changes in pretreatment and post-treatment AFP level (A), platelet count (B), APRI (C), and FIB4 index (D) on HCC development in HPC patients without SVRs after IFN therapy (n = 552). AFP = alpha-fetoprotein, APRI = Aminotransferase-to-Platelet Ratio Index, FIB4 = Fibrosis 4, HCC = hepatocellular carcinoma, HPC = hepatitis C, IFN = interferon, SVRs = sustained virological responses.